Carbidopa

CAS 28860-95-9 19 API suppliersSmall Molecule

Overview

Carbidopa is a medication used in the management of Parkinson's disease, often in combination with levodopa. It acts by inhibiting the enzyme aromatic L-amino acid decarboxylase, thereby preventing the conversion of levodopa into dopamine outside the brain.

API suppliers (19)

Suppliers of Carbidopa evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India5China3Japan2Netherlands1Finland1Switzerland1United Kingdom1

Country recorded for 14 of 19 suppliers.

11 of 19 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

NeurologyParkinson's Disease
Verified Supplier Partner

Do you supply Carbidopa? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.